broad
band at 60-75 kDa). Applications include immunoblotting.
Staining of BACE-1 in immunoblotting is specifically
inhibited with BACE-1 immunizing peptide (human,
amino acids 46-62, with C-terminally
Diameter: 25 mm 25 mm 43 mm 62 mm 76 mm
Effective Membrane Area: 0.9 cm 4.1 cm 13.4 cm 28.7 cm 41.8 cm
Hold-up Volume:* 0.07 mL 0.2 mL 0.5 mL 1.2 mL 1.5 mL
Maximum Operating Pressure: 75 psi (5.3 kg/cm2)
Relief
Reserved.
Page 2 of 2
References:
1. Rogosa, M., et al., (1951). J. Bact. 62. 1,132.
2. MacFaddin, J.F., (1985). Media for Isolation-Cultivation-Identification-Maintenance of
. Cell. Biol., 21, 2393-2403 (2001).
61. Horiba, M., et al., J. Clin. Invest., 105, 489-497 (2000).
62. Qi, M., et al., J. Biol. Chem., 276, 15868-15875 (2001).
63. Maeda, N., et al., J. Biol. Chem., 274
Storage Temperature 2-8 °C
CAS RN: 82410-32-0
Synonyms: 9-(1,3-Dihydroxy-2-propoxymethyl)guanine;
2′-Nor-2′-deoxyguanosine; 2′-NDG; BIOLF-62; DHPG;
BW-759U
Product Description
Molecular formula
on agarose.
Anti-CRMP1 specifically recognizes human, rat, and
mouse CRMP1 by immunoblotting, ~62 kDa. Staining of
the CRMP1 band in immunoblotting is specifically
inhibited by the immunizing peptide
cycles.
Figure 1.
SDS-PAGE Gel of Lot Number 041M0992:
>75% (densitometry)
Figure 2.
Specific Activity of Lot Number 041M0992:
62 nmole/min/mg
Procedure
Preparation Instructions
Kinase Assay
cycles.
Figure 1.
SDS-PAGE Gel of Lot Number 061M0745:
>75% (densitometry)
Figure 2.
Specific Activity of Lot Number 061M0745:
62 nmole/min/mg
Procedure
Preparation Instructions
Kinase Assay
cycles.
Figure 1.
SDS-PAGE Gel of Lot Number 031M0757:
>75% (densitometry)
Figure 2.
Specific Activity of Lot Number 031M0757:
62 nmole/min/mg
Procedure
Preparation Instructions
Kinase Assay
cycles.
Figure 1.
SDS-PAGE Gel of Lot Number 020M0846:
>75% (densitometry)
Figure 2.
Specific Activity of Lot Number 020M0846:
62 nmole/min/mg
Procedure
Preparation Instructions
Kinase Assay
cycles.
Figure 1.
SDS-PAGE Gel of Lot Number 019K1606:
>75% (densitometry)
Figure 2.
Specific Activity of Lot Number 019K1606:
62 nmole/min/mg
Procedure
Preparation Instructions
Kinase Assay
cycles.
Figure 1.
SDS-PAGE Gel of Lot Number 039K0624:
>75% (densitometry)
Figure 2.
Specific Activity of Lot Number 039K0624:
62 nmole/min/mg
Procedure
Preparation Instructions
Kinase Assay
cycles.
Figure 1.
SDS-PAGE Gel of Lot Number 050M0844:
>75% (densitometry)
Figure 2.
Specific Activity of Lot Number 050M0844:
62 nmole/min/mg
Procedure
Preparation Instructions
Kinase Assay
cycles.
Figure 1.
SDS-PAGE Gel of Lot Number 020M0849:
>75% (densitometry)
Figure 2.
Specific Activity of Lot Number 020M0849:
62 nmole/min/mg
Procedure
Preparation Instructions
Kinase Assay
agarose.
Anti-CRMP2 specifically recognizes human, rat, and
mouse CRMP2 by immunoblotting (62 kDa). Staining
of the CRMP2 band in immunoblotting is specifically
inhibited by the immunizing peptide
Anti-CRMP1 (N-terminal) specifically recognizes human,
rat, and mouse CRMP1 by immunoblotting, ~62 kDa.
Staining of the CRMP1 band in immunoblotting is
specifically inhibited by the immunizing peptide
of -amylases from
different strains of Bacillus licheniformis have been
published:
NCIB 6346:2 62 kDa
44MB82-A:5 58 kDa
MTCC 1483:6 58 kDa
Crystal structures for -amylase from B. licheniformis
determine their optimum working
dilutions by titration.
References
1. Otey, C., et al., Hybridoma, 9, 57-62 (1990).
2. Burridge, K., and Connell, L., Cell Motil., 3, 405-417
(1983).
3. Beckerle, M.